Alembic Pharmaceuticals Ltd. logo

Alembic Pharmaceuticals Ltd. (APLLTD)

Market Closed
29 Jul, 10:00
XNSE XNSE
811. 95
-6.9
-0.8426%
204.94B Market Cap
- P/E Ratio
44% Div Yield
81,696 Volume
- Eps
818.85
Previous Close
Add Transaction
Day Range
802.6 818.25
Year Range
635.8 1,026.2
Want to track APLLTD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Alembic Pharmaceuticals Ltd. (APLLTD) Statistics

Valuation metrics

Market Cap 204.94B
Enterprise value 169.05B
Trailing P/E (ttm) 23.24
Forward P/E -
PEG ratio 1.46
Price/Sales (ttm) 2.13
Price/Book (mrq) 2.76
Enterprise Value/Revenue 2.3
Enterprise Value/EBITDA 15.49

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 81.85K
Average volume (90 days) 146.04K

Price summary

52-Week low 635.8
52-Week high 1,026.2
Beta -
50-Day moving average 792.22
200-Day moving average 759.36

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 11
Trailing annual dividend yield 0.0138%
5-Year annual dividend yield -
Payout ratio 0.32
Dividend Date 7 Aug 2025
Ex-Dividend Date 29 Jul 2025
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.09%
Operating margin 0.2%

Operational effectiveness

Return on assets 0.08%
Return on equity 0.13%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 373.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 34.32
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 10.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 1.76%
Book value per share (mrq) 288.34

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -